ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 131

$565K Total Retail Price of All Prescriptions

Rank: 29 out of 131

509 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $70 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 535 415 78 1 2
SIMVASTATIN 440 383 96 2 1
METOPROLOL TARTRATE 385 314 77 3 8
MIRTAZAPINE 343 325 61 4 35
WARFARIN SODIUM 335 299 56 5 10
CITALOPRAM HBR 304 235 45 6 31
LEVOTHYROXINE SODIUM 281 258 40 7 3
ALBUTEROL SULFATE 245 213 54 8 73
QUETIAPINE FUMARATE 238 193 34 A 9 30
LISINOPRIL 227 210 56 10 6
TAMSULOSIN HCL 191 161 38 11 25
IPRATROPIUM BROMIDE 183 147 32 12 96
METFORMIN HCL 173 157 39 13 9
FUROSEMIDE 171 156 55 14 4
LACTULOSE 169 128 46 15 59
PANTOPRAZOLE SODIUM 167 138 40 16 48
LEVETIRACETAM 167 99 33 16 41
RANITIDINE HCL 152 100 39 18 43
ENALAPRIL MALEATE 150 134 28 19 23
CLOPIDOGREL 144 127 29 20 13
RISPERIDONE 144 100 26 A 20 51
NAMENDA 143 118 15 22 20
DONEPEZIL HCL 141 136* 28 23 22
CARVEDILOL 135 116 29 24 26
SANTYL 126 113 34 25 138
JANUVIA 122 <11 <11 26 28
OLANZAPINE 117 101 18 A 27 89
HYDRALAZINE HCL 108 83 19 28 105
LATANOPROST 103 91 28 29 192
FAMOTIDINE* 97 65 19 30 45
VALPROIC ACID* 97 81 22 30 194
DIVALPROEX SODIUM 96 70 15 32 77
OMEPRAZOLE 96 75 30 32 5
MUPIROCIN* 95 74 34 34 78
TRAZODONE HCL 93 82 25 35 44
NYSTATIN 90 77 34 36 95
SERTRALINE HCL 89 84* 18 37 24
BRIMONIDINE TARTRATE 89 69 15 37 218
CHLORHEXIDINE GLUCONATE 84 <11 <11 39 119
CYMBALTA 83 <11 <11 40 60
CARBIDOPA-LEVODOPA 81 81 13 41 84
FINASTERIDE 78 73* 17 42 70
ABILIFY 77 <11 <11 A 43 94
LEVEMIR 74 56 22 44 199
TRAVATAN Z 70 65* 14 45 197
GABAPENTIN 67 56 28 46 19
LOSARTAN POTASSIUM 66 51 19 47 15
POLYETHYLENE GLYCOL 3350 61 56* 12 48 53
PREDNISONE 58 37 13 49 49
NOVOLOG FLEXPEN 57 46 23 50 135
XARELTO 57 <11 <11 50 235
CLOTRIMAZOLE-BETAMETHASONE 57 52* 20 50 87
HALOPERIDOL 56 51* 20 A 53 121
HYDROCHLOROTHIAZIDE 55 41 13 54 12
ALLOPURINOL 54 <11 <11 55 41
LAMOTRIGINE 51 <11 <11 56 155
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.